stibophen

{{Short description|Chemical compound}}

{{Drugbox

| Watchedfields = changed

| verifiedrevid = 387475262

| IUPAC_name = Pentasodium 2-(2-oxido-3,5-disulfonatophenoxy)-1,3,2-benzodioxastibole-5,7-disulfonate

| image = Stibophen.png

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|correct|CAS}}

| CAS_number = 23940-36-5

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = EF31LJY4KN

| ATC_prefix = P02

| ATC_suffix = BX03

| PubChem = 16683091

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| ChemSpiderID = 17615576

| chemical_formula =

| C=12 | H=4 | Na=5 | O=16 | S=4 | Sb=1

| smiles = C1=C(C=C2C(=C1S(=O)(=O)[O-])O[Sb](O2)OC3=CC(=CC(=C3[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+]

| StdInChI = 1S/2C6H6O8S2.5Na.7H2O.Sb/c2*7-4-1-3(15(9,10)11)2-5(6(4)8)16(12,13)14;;;;;;;;;;;;;/h2*1-2,7-8H,(H,9,10,11)(H,12,13,14);;;;;;7*1H2;/q;;5*+1;;;;;;;;+3/p-8

| StdInChIKey = ZDDUXABBRATYFS-UHFFFAOYSA-F

}}

Stibophen is an anthelmintic originally developed by Bayer that is used as a treatment for schistosomiasis{{cite journal | vauthors = Miller MJ, Lyon HP | title = Treatment of vesical schistosomiasis with stibophen | journal = The American Journal of Tropical Medicine and Hygiene | volume = 4 | issue = 6 | pages = 1049–56 | date = November 1955 | pmid = 13268811 | doi = 10.4269/ajtmh.1955.4.1049 }} by intramuscular injection. It is classified as a trivalent antimony compound. Brand names include Fouadin/Fuadin (named in honor of Fuad I of Egypt, who had enthusiastically supported its research and development).{{cite journal | vauthors = Khalil M, Betache MH | title = Treatment of Bilharziasis With a New Compound 'Fouadin.' | journal = Lancet | volume = 215 | issue = 5553 | pages = 234–35 | date = February 1930 | doi = 10.1016/S0140-6736(00)87344-4 }}{{cite journal | vauthors = Williamson TV, Dodson AI | title = The Specific Effect of 'Fouadin' (Fuadin) on Granuloma Inguinale: Preliminary Report | journal = JAMA | volume = 100 | issue = 21 | pages = 1671–76 | date = May 1933 | doi = 10.1001/jama.1933.02740210019007 }}